Many patients suffering from psychosis are nonadherent to their medications. Nonadherence can range from treatment refusal to irregular use or partial change in daily medication doses.
Aim:
To investigate whether symptom dimensions, post-discharge care plans and being involved with faith healer affect the adherence to treatment in patients with schizophrenia.
Method:
A total of 121 patients with schizophrenia were examined 6 weeks post-discharge from the inpatient unit and assessed for full, partial or nonadherence to medication.
Results:
There was a significant association between family involvement and partial adherence and between community team involvement post-discharge and full adherence to medications. Psycho-education was a predictor for adherence to medications, persecutory delusions and lack of insight predicted partial adherence, while being involved with faith healers predicted nonadherence.
Conclusion:
Adherence to medications and socio-demographic variables are independent. This study demonstrated that nonadherence or partial adherence to medications is associated with lack of insight and persecutory delusions. Psycho-education could improve the adherence to medication compliances.
Abou-SalehM. T.GhubashR.DardkehT. K. (2001). Al Ain community psychiatric survey. I. Prevalence and socio-demographic correlates. Social Psychiatry & Psychiatric Epidemiology, 36, 20–28.
2.
AcostaF.BoschE.SarmientoG.JuanesN.Caballero-HidalgoA.MayansT. (2009). Evaluation of noncompliance in schizophrenia patients using electronic monitoring (MEMS) and its relationship to sociodemographic, clinical and psychopathological variables. Schizophrenia Research, 107, 213–217.
3.
AldebotS.de MamaniA. (2009). Denial and acceptance coping styles and medication adherence in schizophrenia. Journal of Nervous and Mental Disease, 197, 580–584.
4.
American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
5.
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author.
6.
American Psychiatric Association. (2004). Guidelines for treatment of schizophrenia. Washington, DC: Author.
7.
BaekelandF.LundwallL. (1975). Dropping out of treatment: A critical review. Psychological Bulletin, 82, 738–783.
8.
BäumlJ.FroböseT.KraemerS.RentropM.Pitschel-WalzG. (2006). Psychoeducation: A basic psychotherapeutic intervention for patients with schizophrenia and their families. Schizophrenia Bulletin, 32(Suppl. 1), S1–S9.
9.
BodenR. (2011). Early non-adherence to medication and other risk factors for rehospitalization in schizophrenia and schizoaffective disorder. Schizophrenia Research, 133, 36–41.
10.
BuchananA. (1998). Treatment compliance in schizophrenia. Advances in Psychiatric Treatment, 4, 227–234.
11.
DardkehT. K.EapenV.GhubashR. (2005). Mental morbidity in primary care in Al Ain (UAE): Application of the Arabic translation of the PRIME-MD (PHQ) version. German Journal of Psychiatry, 8, 32–35.
12.
DixonL.AdamsC.LuckstedA. (2000). Update on family psychoeducation for schizophrenia. Schizophrenia Bulletin, 26, 137–139.
13.
El-RufaieO. E. F. A.AbsoodG. (1993). Minor psychiatric morbidity in primary health care: Prevalence, nature, and severity. International Journal of Social Psychiatry, 39, 159–166.
14.
FirstM. B.GibbonM.SpitzerR. L.WilliamsJ. B. W.BenjaminL. S. (1997). Structured Clinical Interview for DSM-IV Axis II Personality Disorders, (SCID-II). Washington, DC: American Psychiatric Press.
15.
HigashiK.MedicG.LittlewoodK. J.DiezT.GranströmO.De HertM. (2013). Medication adherence in schizophrenia: Factors influencing adherence and consequences of nonadherence, a systematic literature review. Therapeutic Advances in Psychopharmacology, 3, 200–218.
16.
HudsonT.OwenR.ThrushC.HanX.PyneJ.ThapaP.SullivanG. (2004). A pilot study of barriers to medication adherence in schizophrenia. Journal of Clinical Psychiatry, 65, 211–216.
17.
JanssenB.GaebelW.HaerterM.KomaharadiF.LindelB.WeinmannS. (2006). Evaluation of factors influencing medication compliance in inpatient treatment of psychotic disorders. Psychopharmacology, 187, 229–236.
18.
LeuchtS.HeresS. (2006). Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia. Journal of Clinical Psychiatry, 67(5), 3–8.
19.
LeyP.MorrisL. (1984). Psychological aspects of written information for patients. In RachmanS. (Ed.), Contributions to medical psychology (Vol. 3, pp. 117–149). Oxford, UK: Pergamon Press.
20.
LindenM.GodemannF.GaebelW.KopkeW.MullerP.Muller-SpahnF. (2001). A prospective study of factors influencing adherence to a continuous neuroleptic treatment program in schizophrenia patients during 2 years. Schizophrenia Bulletin, 27, 585–596.
21.
Liu-SeifertH. (2012). Factors associated with adherence to treatment with olanzapine and other atypical antipsychotic medications in patients with schizophrenia. Comprehensive Psychiatry, 53, 107–115.
22.
LlorcaP. (2008). Partial compliance in schizophrenia and the impact on patient outcomes. Psychiatry Research, 161, 235–247.
23.
LofflerW.KilianR.ToumiM.AngermeyerM. (2003). Schizophrenic patients’ subjective reasons for compliance and noncompliance with neuroleptic treatment. Pharmacopsychiatry, 36, 105–112.
24.
MufaddelA.AlSabousiM.TakritiY.SalehB. (2014). Community mental health services in AlAin Hospital, United Arab Emirates. International Psychiatry, 11, 18–20.
25.
OlfsonM.MarcusS.WilkJ.WestJ. (2006). Awareness of illness and nonadherence to antipsychotic medications among persons with schizophrenia. Psychiatry Service, 57, 205–211.
26.
PekkalaE.MerinderL. (2002). Psychoeducation for schizophrenia. Cochrane Database of Systematic Reviews, 2, CD002831.
27.
SalemM. O.MoselhyH. F.AttiaH.YousefS. (2008). Clinical characteristics of first episode psychosis: A retrospective study in Al Ain, United Arab Emirates. The Arab Journal of Psychiatry, 19, 25–35.
28.
SciorK.HamidA.MahfoudhiA.AbdallaF. (2013). The relationship between awareness of intellectual disability, causal and intervention beliefs and social distance in Kuwait and the UK. Research in Developmental Disabilities, 34, 3896–3905.
29.
SvestkaJ.BitterI. (2007). Nonadherence to antipsychotic treatment in patients with schizophrenic disorders. Neuroendocrinology Letters, 28(1), 95–116.
30.
ValensteinM.BlowF.CopelandL.McCarthyJ.ZeberJ.GillonL.… StavengerT. (2004). Poor antipsychotic adherence among patients with schizophrenia: Medication and patient factors. Schizophrenia Bulletin, 30, 255–264.
31.
van OsJ.KapurS. (2009). Schizophrenia. The Lancet, 374, 635–645.
32.
VelliganD.WeidenP.SajatovicM.ScottJ.CarpenterD.RossR., & Expert Consensus Panel on Adherence Problems in Serious and Persistent Mental Illness. (2009). The expert consensus guideline series: Adherence problems in patients with serious and persistent mental illness. Journal of Clinical Psychiatry, 70(4), 1–46.
33.
World Health Organization. (2003). Adherence to long-term therapies: Evidence for action. Geneva, Switzerland: Author.
